查看購物車
  • Simplified Chinese
  • English
  • Japanese
全球結構性心臟疾病設備市場：按程序、產品、最終用戶、地區分類 - 預測至 2029 年
市場調查報告書
商品編碼
1614463

全球結構性心臟疾病設備市場：按程序、產品、最終用戶、地區分類 - 預測至 2029 年

Structural Heart Devices Market by Product (Heart Valve Devices Transcatheter and Surgical), Occluders, Closure and Delivery Systems, Annuloplasty Rings, Accessories, Procedure (Replacement(TAVR/TAVI)), Repair & End-Users-Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 305 Pages | 訂單完成後即時交付

價格

全球結構性心臟疾病器材市場規模預計將從2024年的163.1億美元增至2029年的256.9億美元，2024年至2029年複合年成長率為9.5%，備受關注。

推動結構性心臟疾病器材市場成長的因素包括瓣膜性心臟病和先天性心臟疾病盛行率上升、TAVR和TMVR等微創技術的高速進步、全球人口老化和醫療保健水平下降這包括由於強化而提高的採用率。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（美元）
按細分市場 按程式、產品、最終用戶、地區
目標區域 北美、歐洲、亞太地區、中東/非洲

結構性心臟疾病器械市場最重要的部分是心臟瓣膜，這主要是由於主動脈瓣狹窄和瓣膜閉鎖不全等瓣膜疾病的高盛行率，尤其是在老年人群中。這些都需要早期治療，微創技術的最新突破是TAVR和TMVR，大大改變了這些疾病的治療方法。與傳統的心臟直視手術相比，上述手術可以縮短恢復時間，降低手術風險，並增加接觸高風險或無法手術患者的機會。

例如，技術升級（例如具有更高耐用性、改進密封性和最佳化輸送機制的下一代閥門）已成為該細分市場最重要的需求促進因素之一。 Edwards Lifesciences、Medtronic 和 Abbott 正在大力投資開發先進的經導管心臟瓣膜，進一步鞏固他們在這一領域的主導地位。此外，在不斷成長的報銷政策和經過驗證的臨床成功率的支持下，這些產品在已開發市場和新興市場的日益普及，使心臟瓣膜領域成為最大且成長最快的結構性心臟市場，我們正在進一步加強這一類別。

該報告研究了全球結構性心臟疾病設備市場，包括按程序、產品、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 產業動態
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 投資金籌措場景
  • 技術分析
  • 專利分析
  • 貿易分析
  • 2024-2025年重大會議和活動
  • 案例研究分析
  • 監管狀況
  • 波特五力分析
  • 主要相關人員和採購標準
  • 報銷分析
  • 未滿足的需求和最終用戶的期望
  • 人工智慧/產生人工智慧對結構性心臟疾病設備市場的影響

第6章 結構性心臟疾病器材市場（依手術方式）

  • 介紹
  • 置換術
  • 修復技術

第7章 結構性心臟疾病器材市場（分產品）

  • 介紹
  • 心臟瓣膜裝置
  • 封堵器、閉合系統和輸送系統
  • 環狀成形術環
  • 配件

第8章 結構性心臟疾病器材市場（依最終用戶分類）

  • 介紹
    • 醫院
    • 門診手術中心
    • 其他

第9章 結構性心臟疾病器材市場（按地區）

  • 介紹
  • 北美洲
    • 北美宏觀經濟展望
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲宏觀經濟展望
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 亞太宏觀經濟展望
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 拉丁美洲宏觀經濟展望
    • 巴西
    • 墨西哥
    • 其他
  • 中東/非洲
    • 中東和非洲宏觀經濟前景
    • 海灣合作理事會國家
    • 其他

第10章競爭格局

  • 介紹
  • 主要參與企業的策略/優勢
  • 2019-2023年收益分析
  • 2023 年市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 品牌/產品比較
  • 企業價值評估及財務指標
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • EDWARDS LIFESCIENCES CORPORATION
    • MEDTRONIC
    • ABBOTT
    • BOSTON SCIENTIFIC CORPORATION
    • TELEFLEX
    • INTEGER HOLDINGS CORPORATION
    • LEPU MEDICAL TECHNOLOGY CO., LTD.
    • TTK HEALTHCARE
    • ARTIVION, INC.
    • VENUS MEDTECH（HANGZHOU）INC.
    • LIFETECH SCIENTIFIC CORPORATION
    • COOK
    • CORDIS
    • SMT
    • MERIL LIFE SCIENCES PVT. LTD.
    • WL GORE & ASSOCIATES, INC.
  • 其他公司
    • FOLDAX
    • MICRO INTERVENTIONAL DEVICES, INCORPORATED
    • CARDIAC DIMENSIONS
    • BIOTRONIK
    • HIGHLIFE MEDICAL
    • MITRALIGN
    • BRAILE BIOMEDICA
    • JENAVALVE
    • CORCYM
    • XELTIS
    • INNOVHEART SRL

第12章附錄

Product Code: MD 6585

The global Structural heart devices market is projected to reach USD 25.69 billion by 2029 from USD 16.31 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. Drivers of growth in the market for structural heart devices include mounting incidence rates of valvular and congenital heart diseases, high advancement rates of minimally invasive technologies such as TAVR and TMVR, and rising adoption rates since global populations are aging and healthcare infrastructure is being enhanced.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product, Procedure, End Users and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

"By product segment Heart Valve segment to account for the largest share during the forecast period"

The most paramount segment of the structural heart devices market is heart valves primarily due to the higher prevalence of valvular diseases such as aortic stenosis and mitral regurgitation, especially in the geriatric population. These have treatment requirements at the earlier stages, with the latest breakthroughs in minimally invasive techniques being TAVR and TMVR, which have drastically altered the approach to treating these diseases. The above techniques offer reduced recovery times, fewer surgical risks, and greater access to patients classified as high-risk or inoperable when compared to traditional open-heart surgery.

Technological upgrades, for example, next-generation valves with improved durability, better sealing, and optimized delivery mechanisms form one of this segment's most important demand drivers. Edwards Lifesciences, Medtronic, and Abbott companies are heavily investing in developing advanced transcatheter heart valves, thus further strengthening the dominancy of the segment. In addition, the growing adoption of these products in developed and emerging markets, supported by growth in reimbursement policies and demonstrated clinical success rates, further solidifies the heart valve segment as the largest and fastest-growing category in the structural heart market.

"APAC is estimated to register the highest CAGR during the forecast period."

The Structural heart devices market is divided into Five regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific region witnessed the highest CAGR during the forecast period. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. The increasing diabetic population and increase in obesity due to sedentary lifestyles are also driving the growth of Structural heart devices in the APAC region.

The breakdown of the profile of primary participants in the Structural heart devices market:

  • By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
  • By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
  • By Region: North America - 40%, Europe - 30%, APAC -20%, Latin America - 5%, Middle East & Africa-5%

List of Companies Profiled in the Report

  • Boston Scientific Corporation (U.S)
  • Edwards Lifesciences Corporation (U.S)
  • Medtronic (Ireland)
  • Boston Scientific Corporation (U.S
  • Abbott (U.S)
  • Teleflex (U.S)
  • Integer Holdings Corporation (U.S)
  • Lepu Medical Technology Co.Ltd.(China)
  • TTK (India)
  • Artivion, Inc. (U.S)
  • Venus Medtech, Inc. (China)
  • Cook (U.S)
  • SMT (India)
  • Meril Lifesciences Pvt.Ltd (India)
  • W.L Gore & Associates, Inc. (U.S)
  • Cordis (U.S)
  • Foldax (U.S)
  • Micro Interventional Devices, Incorporated (U.S)
  • Cardiac Dimensions (U.S)
  • HighLife Medical (France)
  • Mitralign (U.S)
  • Braile Biomedica (Brazil)
  • JenaValve (Germany)
  • Corcym (Italy)
  • Xeltis (Switzerland)
  • Innovheart SRL (U.S)

Research Coverage

This report studies the Structural heart devices market based on product, procedure, end users and region. It also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the market's opportunities and challenges for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Structural heart devices market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

  • Analysis of key drivers (technological advancements), restraints (Cost of the system), challenges (regulatory policies), and opportunities (Increase in minimally invasive procedures) contributing to the growth of the Structural heart devices market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Structural heart devices market.
  • Market Development: Comprehensive information on the lucrative emerging markets type and region.
  • Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Structural heart devices market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Structural heart devices market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 TOP-DOWN APPROACH
    • 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.2.4 DEMAND-SIDE ANALYSIS
  • 2.3 GROWTH FORECAST
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE ANALYSIS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
  • 2.8 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 STRUCTURAL HEART DEVICES MARKET OVERVIEW
  • 4.2 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT AND COUNTRY
  • 4.3 STRUCTURAL HEART DEVICES MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population
      • 5.2.1.2 Increasing preference for minimally invasive surgeries
      • 5.2.1.3 Rising awareness about structural heart diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of devices and limited reimbursement
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emergence of tissue-engineered heart valves
      • 5.2.3.2 Expanding healthcare facilities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Regulatory and approval challenges
      • 5.2.4.2 Intense competition among market players
      • 5.2.4.3 Lack of skilled professionals
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 MINIMALLY INVASIVE PROCEDURES
    • 5.3.2 TECHNOLOGICAL ADVANCEMENTS IN DEVICE DESIGN
    • 5.3.3 AI AND MACHINE LEARNING INTEGRATION
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.5.2 AVERAGE SELLING PRICE, BY KEY PLAYER
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Transcatheter aortic valve replacement
      • 5.10.1.2 Transcatheter mitral aortic valve replacement
    • 5.10.2 COMPLEMENTARY TECHNOLOGIES
      • 5.10.2.1 3D printing
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 HS CODES
    • 5.12.2 EXPORT DATA
    • 5.12.3 IMPORT DATA
  • 5.13 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 SAPIEN 3 TRANSCATHETER HEART VALVE FOR PRECISION PLACEMENT
    • 5.14.2 MITRACLIP TRANSCATHETER EDGE-TO-EDGE REPAIR TO REDUCE HOSPITALIZATION
    • 5.14.3 WATCHMAN FLX DEVICE FOR LEFT ATRIAL APPENDAGE
  • 5.15 REGULATORY LANDSCAPE
    • 5.15.1 REGULATORY ANALYSIS
      • 5.15.1.1 North America
        • 5.15.1.1.1 US
        • 5.15.1.1.2 Canada
      • 5.15.1.2 Europe
      • 5.15.1.3 Asia Pacific
        • 5.15.1.3.1 Japan
        • 5.15.1.3.2 China
    • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.16 PORTER'S FIVE FORCE ANALYSIS
    • 5.16.1 THREAT OF NEW ENTRANTS
    • 5.16.2 THREAT OF SUBSTITUTES
    • 5.16.3 BARGAINING POWER OF SUPPLIERS
    • 5.16.4 BARGAINING POWER OF BUYERS
    • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS
    • 5.17.2 BUYING CRITERIA
  • 5.18 REIMBURSEMENT ANALYSIS
  • 5.19 UNMET NEEDS AND END-USER EXPECTATIONS
    • 5.19.1 UNMET NEEDS
    • 5.19.2 END-USER EXPECTATIONS
  • 5.20 IMPACT OF AI/GEN AI ON STRUCTURAL HEART DEVICES MARKET
    • 5.20.1 INTRODUCTION
    • 5.20.2 KEY COMPANIES IMPLEMENTING AI
    • 5.20.3 MARKET POTENTIAL OF AI IN STRUCTURAL HEART DEVICES MARKET

6 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE

  • 6.1 INTRODUCTION
  • 6.2 REPLACEMENT PROCEDURES
    • 6.2.1 TAVR/TAVI REPLACEMENT PROCEDURES
      • 6.2.1.1 Quicker recuperation and shorter hospital stays to promote growth
    • 6.2.2 SAVR PROCEDURES
      • 6.2.2.1 Wide adoption for treating valvular heart diseases to sustain growth
  • 6.3 REPAIR PROCEDURES
    • 6.3.1 CLOSURE PROCEDURES
      • 6.3.1.1 Increasing prevalence of structural heart defects to boost market
    • 6.3.2 ANNULOPLASTY
      • 6.3.2.1 Growing focus on safety and efficacy to drive market
    • 6.3.3 VALVULOPLASTY
      • 6.3.3.1 Increasing cases of aortic stenosis and valvular regurgitation to fuel market
    • 6.3.4 TMVR PROCEDURES
      • 6.3.4.1 Growing preference over valve replacement to promote growth
    • 6.3.5 TEER PROCEDURES
      • 6.3.5.1 Global prevalence of mitral regurgitation to expedite growth

7 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
  • 7.2 HEART VALVE DEVICES
    • 7.2.1 TRANSCATHETER HEART VALVES
      • 7.2.1.1 Transcatheter mitral valve replacement
        • 7.2.1.1.1 Growing use in treating age-related degeneration and heart diseases to boost market
      • 7.2.1.2 Transcatheter aortic valve replacement
        • 7.2.1.2.1 Increasing instances of aortic valve replacement to aid growth
    • 7.2.2 SURGICAL VALVES
      • 7.2.2.1 Mechanical valves
        • 7.2.2.1.1 Higher durability and affordability to encourage growth
      • 7.2.2.2 Biological valves
        • 7.2.2.2.1 Need for reduced incidence of bleeding to accelerate growth
  • 7.3 OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS
  • 7.4 ANNULOPLASTY RINGS
    • 7.4.1 HIGH PREVALENCE OF MITRAL AND TRICUSPID VALVE REGURGITATION DISEASES TO PROMOTE GROWTH
  • 7.5 ACCESSORIES
    • 7.5.1 CATHETERS
      • 7.5.1.1 Growing preference for minimally invasive procedures to fuel market
    • 7.5.2 GUIDEWIRES
      • 7.5.2.1 Need for precise navigation and placement of medical devices to augment growth
    • 7.5.3 SHEATHS
      • 7.5.3.1 Need for minimizing vascular trauma to promote growth
    • 7.5.4 OTHER ACCESSORIES

8 STRUCTURAL HEART DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • 8.1.1 HOSPITALS
      • 8.1.1.1 Ability to handle large volume of patients to boost market
    • 8.1.2 AMBULATORY SURGICAL CENTRES
      • 8.1.2.1 Faster procedure time and lower infection rates to drive market
    • 8.1.3 OTHER END USERS

9 STRUCTURAL HEART DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Favorable reimbursement scenario to augment growth
    • 9.2.3 CANADA
      • 9.2.3.1 Rising prevalence of target diseases to drive market
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Increase in geriatric and obese population to stimulate growth
    • 9.3.3 UK
      • 9.3.3.1 Increasing incidence of peripheral vascular diseases to support growth
    • 9.3.4 FRANCE
      • 9.3.4.1 Favorable government initiatives to drive market
    • 9.3.5 ITALY
      • 9.3.5.1 Increasing health expenditure and rising diabetes prevalence to boost market
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing geriatric population to propel market
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Increasing healthcare expenditure to boost market
    • 9.4.3 CHINA
      • 9.4.3.1 Growing target patient population to drive market
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing prevalence of diabetes to expedite growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing hospitalizations due to coronary artery diseases to fuel market
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increasing prevalence of hypertension to support growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Rising healthcare expenditure to aid growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Increasing prevalence of cardiovascular diseases to spur growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Rising cases of hypertension and associated cardiovascular diseases to drive market
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE ANALYSIS, 2019-2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Product footprint
      • 10.5.5.3 Procedure footprint
      • 10.5.5.4 End-user footprint
      • 10.5.5.5 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 COMPANY VALUATION AND FINANCIAL METRICS
    • 10.8.1 FINANCIAL METRICS
    • 10.8.2 COMPANY VALUATION
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 10.9.2 DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 EDWARDS LIFESCIENCES CORPORATION
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 MEDTRONIC
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches and approvals
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 ABBOTT
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches and approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 BOSTON SCIENTIFIC CORPORATION
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches and approvals
    • 11.1.5 TELEFLEX
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches and approvals
        • 11.1.5.3.2 Deals
    • 11.1.6 INTEGER HOLDINGS CORPORATION
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
        • 11.1.6.3.2 Expansions
    • 11.1.7 LEPU MEDICAL TECHNOLOGY CO., LTD.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches and approvals
    • 11.1.8 TTK HEALTHCARE
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
    • 11.1.9 ARTIVION, INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 VENUS MEDTECH (HANGZHOU) INC.
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Product launches and approvals
    • 11.1.11 LIFETECH SCIENTIFIC CORPORATION
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 COOK
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Deals
    • 11.1.13 CORDIS
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product launches and approvals
    • 11.1.14 SMT
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Other developments
    • 11.1.15 MERIL LIFE SCIENCES PVT. LTD.
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
    • 11.1.16 W. L. GORE & ASSOCIATES, INC.
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 FOLDAX
    • 11.2.2 MICRO INTERVENTIONAL DEVICES, INCORPORATED
    • 11.2.3 CARDIAC DIMENSIONS
    • 11.2.4 BIOTRONIK
    • 11.2.5 HIGHLIFE MEDICAL
    • 11.2.6 MITRALIGN
    • 11.2.7 BRAILE BIOMEDICA
    • 11.2.8 JENAVALVE
    • 11.2.9 CORCYM
    • 11.2.10 XELTIS
    • 11.2.11 INNOVHEART SRL

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2020-2023
  • TABLE 2 STRUCTURAL HEART DEVICES MARKET: RESEARCH ASSUMPTIONS
  • TABLE 3 STRUCTURAL HEART DEVICES MARKET: RISK ASSESSMENT
  • TABLE 4 GERIATRIC POPULATION, BY REGION, 2030
  • TABLE 5 NATIONAL AVERAGE REIMBURSEMENT RATES FOR NORTH AMERICA AND EUROPE, 2024-2025
  • TABLE 6 STRUCTURAL HEART DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 STRUCTURAL HEART DEVICES MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2023
  • TABLE 8 HS CODES FOR STRUCTURAL HEART DEVICES MARKET
  • TABLE 9 EXPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023
  • TABLE 10 IMPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023
  • TABLE 11 STRUCTURAL HEART DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 STRUCTURAL HEART DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
  • TABLE 19 KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
  • TABLE 20 CPT CODES FOR STRUCTURAL HEART DEVICES MARKET
  • TABLE 21 STRUCTURAL HEART DEVICES MARKET: UNMET NEEDS
  • TABLE 22 STRUCTURAL HEART DEVICES MARKET: END-USER EXPECTATIONS
  • TABLE 23 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 24 STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 25 STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 STRUCTURAL HEART DEVICES MARKET FOR TAVR/TAVI PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 STRUCTURAL HEART DEVICES MARKET FOR SAVR PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 STRUCTURAL HEART DEVICES MARKET FOR CLOSURE PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 STRUCTURAL HEART DEVICES MARKET FOR VALVULOPLASTY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 STRUCTURAL HEART DEVICES MARKET FOR TMVR PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 STRUCTURAL HEART DEVICES MARKET FOR TEER PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 36 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 37 STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY REGION, 2022-2029 (THOUSAND UNITS)
  • TABLE 38 STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 STRUCTURAL HEART DEVICES MARKET FOR MECHANICAL VALVES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 STRUCTURAL HEART DEVICES MARKET FOR BIOLOGICAL VALVES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 STRUCTURAL HEART DEVICES MARKET FOR OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY RINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 48 STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 STRUCTURAL HEART DEVICES MARKET FOR CATHETERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 STRUCTURAL HEART DEVICES MARKET FOR GUIDEWIRES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 STRUCTURAL HEART DEVICES MARKET FOR SHEATHS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 STRUCTURAL HEART DEVICES MARKET FOR OTHER ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 54 STRUCTURAL HEART DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 STRUCTURAL HEART DEVICES MARKET FOR AMBULATORY SURGICAL CENTRES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 STRUCTURAL HEART DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: HEART VALVE DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 68 US: KEY MACROECONOMIC INDICATORS
  • TABLE 69 US: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 70 US: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 US: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 US: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 73 US: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 US: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 75 US: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 US: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 US: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 78 CANADA: KEY MACROECONOMIC INDICATORS
  • TABLE 79 CANADA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 80 CANADA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 CANADA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 CANADA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 CANADA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 CANADA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 85 CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 CANADA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 90 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 95 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 98 GERMANY: KEY MACROECONOMIC INDICATORS
  • TABLE 99 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022- 2029 (USD MILLION)
  • TABLE 100 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 GERMANY: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 105 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 108 UK: KEY MACROECONOMIC INDICATORS
  • TABLE 109 UK: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 110 UK: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 UK: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 UK: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 UK: STRUCTURAL HEART DEVICES FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 UK: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 115 UK: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 UK: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 UK: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 118 FRANCE: KEY MACROECONOMIC INDICATORS
  • TABLE 119 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 120 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 FRANCE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 125 FRANCE: STRUCTURAL HEART DEVICES FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 128 ITALY: KEY MACROECONOMIC INDICATORS
  • TABLE 129 ITALY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 130 ITALY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 ITALY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 ITALY: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 ITALY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 ITALY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 135 ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 ITALY: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 138 SPAIN: KEY MACROECONOMIC INDICATORS
  • TABLE 139 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 140 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 SPAIN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 145 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2030 (MILLION)
  • TABLE 149 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 155 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 168 JAPAN: KEY MACROECONOMIC INDICATORS
  • TABLE 169 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 170 JAPAN: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 175 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 178 CHINA: KEY MACROECONOMIC INDICATORS
  • TABLE 179 CHINA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 180 CHINA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 CHINA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 CHINA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 185 CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 CHINA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 188 INDIA: KEY MACROECONOMIC INDICATORS
  • TABLE 189 INDIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 190 INDIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 INDIA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 INDIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 INDIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 INDIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 195 INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 INDIA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: KEY MACROECONOMIC INDICATORS
  • TABLE 199 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 200 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 AUSTRALIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 AUSTRALIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 205 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 208 SOUTH KOREA: KEY MACROECONOMIC INDICATORS
  • TABLE 209 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 210 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 215 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 218 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 219 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 224 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 227 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 229 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 234 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 237 BRAZIL: KEY MACROECONOMIC INDICATORS
  • TABLE 238 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 239 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 BRAZIL: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 244 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 247 MEXICO: KEY MACROECONOMIC INDICATORS
  • TABLE 248 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 249 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 250 MEXICO: STRUCTURAL HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022-2029 (USD MILLION)
  • TABLE 251 MEXICO: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 253 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 254 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 MEXICO: STRUCTURAL HEART DEVICES, MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 257 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 258 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 263 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 266 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 267 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST & AFRICA: HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022-2029 (USD MILLION)
  • TABLE 270 MIDDLE EAST & AFRICA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 277 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY ACCESSORIES, 2022-2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 GCC COUNTRIES: STRUCTURAL HEART DEVICES, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 293 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 294 STRUCTURAL HEART DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 295 STRUCTURAL HEART DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 296 STRUCTURAL HEART DEVICES MARKET: PROCEDURE FOOTPRINT
  • TABLE 297 STRUCTURAL HEART DEVICES MARKET: END-USER FOOTPRINT
  • TABLE 298 STRUCTURAL HEART DEVICES MARKET: REGION FOOTPRINT
  • TABLE 299 STRUCTURAL HEART DEVICES MARKET: KEY STARTUPS/SMES
  • TABLE 300 STRUCTURAL HEART DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 301 STRUCTURAL HEART DEVICES MARKET: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 302 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 303 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 304 EDWARDS LIFESCIENCES CORPORATION: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 305 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 306 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 307 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- OCTOBER 2024
  • TABLE 308 MEDTRONIC: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 309 ABBOTT: COMPANY OVERVIEW
  • TABLE 310 ABBOTT: PRODUCTS OFFERED
  • TABLE 311 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 312 ABBOTT: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 313 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 314 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 315 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 316 TELEFLEX: COMPANY OVERVIEW
  • TABLE 317 TELEFLEX: PRODUCTS OFFERED
  • TABLE 318 TELEFLEX: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021- OCTOBER 2024
  • TABLE 319 TELEFLEX: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 320 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 321 INTEGER HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 322 INTEGER HOLDINGS CORPORATION: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 323 INTEGER HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021- OCTOBER 2024
  • TABLE 324 LEPU MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 325 LEPU MEDICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 326 LEPU MEDICAL CO, .LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 327 TTK HEALTHCARE: COMPANY OVERVIEW
  • TABLE 328 TTK HEALTHCARE: PRODUCTS OFFERED
  • TABLE 329 ARTIVION, INC.: COMPANY OVERVIEW
  • TABLE 330 ARTIVION, INC.: PRODUCTS OFFERED
  • TABLE 331 VENUS MEDTECH (HANGZHOU) INC.: COMPANY OVERVIEW
  • TABLE 332 VENUS MEDTECH (HANGZHOU) INC.: PRODUCTS OFFERED
  • TABLE 333 VENUS MEDTECH (HANGZHOU) INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 334 LIFETECH SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 335 LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 336 COOK: COMPANY OVERVIEW
  • TABLE 337 COOK: PRODUCTS OFFERED
  • TABLE 338 COOK: DEALS, JANUARY 2021-OCTOBER 2024
  • TABLE 339 CORDIS: COMPANY OVERVIEW
  • TABLE 340 CORDIS: PRODUCTS OFFERED
  • TABLE 341 CORDIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024
  • TABLE 342 SMT: COMPANY OVERVIEW
  • TABLE 343 SMT: PRODUCTS OFFERED
  • TABLE 344 SMT: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
  • TABLE 345 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 346 MERIL LIFESCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 347 W.L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
  • TABLE 348 W.L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 349 FOLDAX: COMPANY OVERVIEW
  • TABLE 350 MICRO INTERVENTIONAL DEVICES, INCORPORATED: COMPANY OVERVIEW
  • TABLE 351 CARDIAC DIMENSIONS: COMPANY OVERVIEW
  • TABLE 352 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 353 HIGHLIFE MEDICAL: COMPANY OVERVIEW
  • TABLE 354 MITRALIGN: COMPANY OVERVIEW
  • TABLE 355 BRAILE BIOMEDICA: COMPANY OVERVIEW
  • TABLE 356 JENAVALVE: COMPANY OVERVIEW
  • TABLE 357 CORCYM: COMPANY OVERVIEW
  • TABLE 358 XELTIS: COMPANY OVERVIEW
  • TABLE 359 INNOVHEART SRL: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE COVERED
  • FIGURE 2 STRUCTURAL HEART DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 6 STRUCTURAL HEART DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 7 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 8 STRUCTURAL HEART DEVICES MARKET: CAGR PROJECTIONS, 2024-2029
  • FIGURE 9 DATA TRIANGULATION
  • FIGURE 10 STRUCTURAL HEART DEVICES, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 STRUCTURAL HEART DEVICES MARKET FOR HEART VALVES, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 STRUCTURAL HEART DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHIC SNAPSHOT OF GLOBAL STRUCTURAL HEART DEVICES MARKET
  • FIGURE 15 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • FIGURE 16 US AND HEART VALVE DEVICES LED NORTH AMERICAN MARKET IN 2023
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 STRUCTURAL HEART DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 INDUSTRY TRENDS IN STRUCTURAL HEART DEVICES MARKET
  • FIGURE 20 STRUCTURAL HEART DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
  • FIGURE 21 AVERAGE SELLING PRICE TREND OF TRANSCATHETER HEART VALVES, BY REGION, 2021-2023 (USD)
  • FIGURE 22 AVERAGE SELLING PRICE TREND OF SURGICAL HEART VALVES, BY REGION, 2021-2023 (USD MILLION)
  • FIGURE 23 AVERAGE SELLING PRICE OF BIOLOGICAL VALVES, BY KEY PLAYER (2023)
  • FIGURE 24 STRUCTURAL HEART DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 STRUCTURAL HEART DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 STRUCTURAL HEART DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 27 STRUCTURAL HEART DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2018-2023
  • FIGURE 28 STRUCTURAL HEART DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014-NOVEMBER 2024
  • FIGURE 29 STRUCTURAL HEART DEVICES MARKET: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL HEART DEVICES, BY PRODUCT
  • FIGURE 31 KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
  • FIGURE 32 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET SNAPSHOT
  • FIGURE 34 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET
  • FIGURE 35 REVENUE ANALYSIS FOR KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET, 2019-2023
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET (2023)
  • FIGURE 37 STRUCTURAL HEART DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 38 STRUCTURAL HEART DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 39 STRUCTURAL HEART DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 40 STRUCTURAL HEART DEVICES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 44 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 TELEFLEX: COMPANY SNAPSHOT (2023)
  • FIGURE 48 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 LEPU MEDICAL CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 TTK HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ARTIVION, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 VENUS MEDTECH (HANGZHOU) INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)